NCT02169154View on ClinicalTrials.gov

A Safety Study to Investigate the Skin Irritancy Potential of Diclofenac-Menthol Gel

PHASE1CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

June 1, 2014

Primary Completion Date

July 1, 2014

Study Completion Date

July 1, 2014

Conditions

Pain

Interventions

DRUG

1% Diclofenac Sodium

1% diclofenac sodium

DRUG

3% Menthol

3% Menthol

DRUG

0.09% Menthol

0.09% Menthol

DRUG

0.2% Sodium Lauryl Sulfate

0.2% Sodium Lauryl Sulfate

DRUG

0.9% Saline

0.9% Saline

Trial Locations (1)

07652

TKL Research Inc, Paramus

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT02169154 - A Safety Study to Investigate the Skin Irritancy Potential of Diclofenac-Menthol Gel | Biotech Hunter | Biotech Hunter